These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23391411)

  • 1. Do stimulants improve functioning in adults with ADHD? A review of the literature.
    Surman CB; Hammerness PG; Pion K; Faraone SV
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):528-33. PubMed ID: 23391411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvements in executive function correlate with enhanced performance and functioning and health-related quality of life: evidence from 2 large, double-blind, randomized, placebo-controlled trials in ADHD.
    Brown TE; Landgraf JM
    Postgrad Med; 2010 Sep; 122(5):42-51. PubMed ID: 20861587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.
    Antshel KM; Kaul P; Biederman J; Spencer TJ; Hier BO; Hendricks K; Faraone SV
    J Clin Psychiatry; 2013 Mar; 74(3):e197-204. PubMed ID: 23561240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to stimulants in adult ADHD.
    O'Callaghan P
    Atten Defic Hyperact Disord; 2014 Jun; 6(2):111-20. PubMed ID: 24604104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of attention deficit hyperactivity disorder in adults].
    Ramos-Quiroga JA; Chalita PJ; Vidal R; Bosch R; Palomar G; Prats L; Casas M
    Rev Neurol; 2012 Feb; 54 Suppl 1():S105-15. PubMed ID: 22374761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the association between stimulant treatment and cognitive outcomes across the life cycle of adults with attention-deficit/hyperactivity disorder: a controlled cross-sectional study.
    Biederman J; Fried R; Petty CR; Henin A; Wozniak J; Corkum L; Claudat K; Faraone SV
    J Nerv Ment Dis; 2012 Jan; 200(1):69-75. PubMed ID: 22210365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of untreated ADHD among adults: the role of stimulant medication.
    Goksøyr PK; Nøttestad JA
    Addict Behav; 2008 Feb; 33(2):342-6. PubMed ID: 17920777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB
    J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey.
    Lensing MB; Zeiner P; Sandvik L; Opjordsmoen S
    J Clin Psychiatry; 2013 Jan; 74(1):e87-93. PubMed ID: 23419235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations.
    Manor I; Rozen S; Zemishlani Z; Weizman A; Zalsman G
    Clin Neuropharmacol; 2011; 34(4):148-54. PubMed ID: 21738027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments.
    Stein MA
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S89-98. PubMed ID: 15352535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.